@bullishbruk Avatar @bullishbruk Bullish

Bullish posts on X about $ibrx, in the, bullish, end of the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

Engagements: [-----] #

Engagements Line Chart

Mentions: [--] #

Mentions Line Chart

Followers: [-----] #

Followers Line Chart

CreatorRank: [-------] #

CreatorRank Line Chart

Social Influence

Social category influence finance 95.5% stocks 9.91% countries 8.11% celebrities 4.5% exchanges 1.8% technology brands 1.8%

Social topic influence $ibrx #4, in the 7.21%, bullish #130, end of 4.5%, we are 4.5%, health 4.5%, this is 3.6%, alc 3.6%, shorts 3.6%, hope 3.6%

Top accounts mentioned or mentioned by @drpatrick @drmakaryfda @lorimills4ca42 @immunitybio @alc2022 @seckennedy @umbisam @nihdirectorjay @alhmd120690 @usfda @vprasadmdmph @adamfeuerstein @newstart2024 @truedat999 @occupydemocrats @spriter99880 @suleimanabdell7 @senronjohnson @fda @potus

Top assets mentioned ImmunityBio, Inc. Common Stock (IBRX) Candel Therapeutics, Inc. (CADL) Iovance Biotherapeutics, Inc. Common Stock (IOVA) Alphabet Inc Class A (GOOGL) Duolingo, Inc. (DUOL) Hims & Hers Health, Inc. (HIMS) BRIXMOR PROPERTY GROUP INC. (BRX) Ambrx Biopharma, Inc. (AMAM) Merck & Co., Inc. (MRK) AST SpaceMobile, Inc. Class A Common Stock (ASTS)

Top Social Posts

Top posts by engagements in the last [--] hours

"Dear Senator Johnson I urge you to investigate the FDAs glaring double standard in oncology approvals. In June [----] the FDA granted Mercks Keytruda a broad tissue-agnostic approval for MSI-high tumors by pooling data from five single-arm trials. Some tumor types had only N=1 or N=2 patients different doses were used and the entire approval rested on this combined dataset (see Tables [--] and [--] page [--] of the June [----] package insert). Big Pharma received accelerated approval on the weakest possible evidence. Yet innovative biotechs developing next-generation immunotherapies including IL-15"
X Link 2026-02-12T18:56Z [----] followers, [----] engagements

"$IBRX the @US_FDA is a captured agency and @DrPatrick ImmunityBios ANKTIVA a (cancer cure) is blocked by BigPharma via @DrMakaryFDA and his legacy get keepers @bullishbruk Have you watch this https://t.co/PlCfHVndRd @bullishbruk Have you watch this https://t.co/PlCfHVndRd"
X Link 2026-02-15T13:42Z [----] followers, [----] engagements

"@I_Am_MikeJones I felt the same way on my recent $AMAM investment had 95K @$4.2sh averaging and when it jump to $6 waited to come down and it didnt and every time it goes up I say lets wait to by the dip but dip never came and one morning I wake up and been sold with a $28 price tag"
X Link 2025-07-09T14:10Z [----] followers, [---] engagements

"$IBRX God has mercy for many and a message through DR. PSS: Glioblastoma. with this life threatening disease and for which there has been little to no advances to extend progression further and sadly early death. #Bioshield #Anktiva TO THE RESCUE @DrMakaryFDA @drkashsarabi @SecKennedy @NIHDirector_Jay @VPrasadMDMPH Please sign the petition. https://chng.it/cR6X5pFCxV Glioblastoma is medicines biggest challenge. For decades and still today the treatment involves surgery followed by radiation with chemo followed by more chemo. At the end of this [--] percent of patients have a low lymphocyte"
X Link 2025-08-26T06:05Z [----] followers, [----] engagements

"$IBRX Neupogen Epogen and thanks to #Anktiva soon there is going to be a therapy for Lymphocytopenia. IMO It will be a standard and part of every chemo therapy regiment and that will be Huge GLTL"
X Link 2025-09-16T02:36Z [----] followers, [----] engagements

"$IBRX I think @DrMakaryFDA @SecKennedy @NIHDirector_Jay knows and I believe as we speak they maybe actively working on the old guard to have a paradigm shift. If you think about it this is undeniable fact and more and more people are getting exposed to it and it will be hard for the @US_FDA just to ignore it. So it is just a matter when ANKTIVA for Lymphopenia is a done deal. must be FDA approved. Working to explain to the world how and why Bioshield works. T cells and NK cells kill cancer thats irrefutable. Low NK cells and T cells means cancer grows thats irrefutable. So if there is a drug"
X Link 2025-10-23T17:05Z [----] followers, [----] engagements

"$IBRX ANKTIVA dont use radiation little to no chemo but cures and kills all type of cancer tumors but @fda refuse to approve IMO they are protecting $mrk Keytruda a $32B revenue drug. @DrMakaryFDA When you live paycheck to paycheck a high copay for an expensive drug can be devastating. We are dramatically lowering drug prices. https://t.co/bFuGmHmNl7 When you live paycheck to paycheck a high copay for an expensive drug can be devastating. We are dramatically lowering drug prices. https://t.co/bFuGmHmNl7"
X Link 2025-10-30T14:52Z [----] followers, [----] engagements

"$IBRX @drpatrick not worried about shorts has poured $3B into @ImmunityBio and the #BioShield platform just won FDA approval for BCG-unresponsive bladder cancer (the first IL-15 superagonist). This is only the opening act. Pipeline in motion: Lung Prostate Pancreas HIV Long COVID Lymphopenia (the silent killer behind millions of chemo/radiation failures) The current price noise Manipulation. But Buying Opportunity What I see A generational opportunity. GLTL 🚀 @alc2022 Thanks. When I developed Abraxane the stock was shorted 100percent until it got approved in [----] and Nasdaq literally had to"
X Link 2025-11-13T15:49Z [----] followers, [----] engagements

"Bullish on $IBRX ImmunityBio just reported $113M in preliminary [----] net product revenue from ANKTIVA a 700% YoY increase. Strong momentum accelerating adoption fresh Saudi FDA approvals (bladder + NSCLC combos) and expanding global + trial pipeline position this for significant long-term upside in oncology. Hypergrowth continues. 📈💪 #IBRX @LoriMills4CA42 @alc2022 https://twitter.com/i/web/status/2011798784938750214 https://twitter.com/i/web/status/2011798784938750214"
X Link 2026-01-15T13:53Z [----] followers, [----] engagements

"$IBRX #ANKTIVA Oncology & Immunotherapy Market Context The global oncology market is massive and growing rapidly estimates range from $250$285B in [----] projected to reach $500$670B+ by [--------] (CAGR 911.5%). The cancer immunotherapy segment (where ANKTIVA fits) is even hotter: $226$260B in [--------] forecasted to hit $443$467B by [----] (CAGR 12%). PD-1/PD-L1 inhibitors (like Keytruda) dominate with the segment at $54$62B in [----] potentially doubling to $120$138B by [----]. IMO A $200B addressable market for ANKTIVA (standalone or combo) aligns with capturing a significant slice of the exploding"
X Link 2026-01-17T01:30Z [----] followers, 10.7K engagements

"$IBRX I have to thank Adam twice first $CAPR $6 to $30 and since he posted a hit job on $IBRX now it is up 6% on a red day. @adamfeuerstein keep it coming my brother. Thank you"
X Link 2026-01-30T18:51Z [----] followers, [----] engagements

"$IBRX The gold standard of randomized controlled trials (RCTs) has always faced scrutinyits not flawless. Look at history: Vioxx sailed through RCTs got FDA approval in [----] then got yanked in [----] after real-world data exposed massive heart attack/stroke risks killing thousands. Belviq passed trials for weight loss approved 2012pulled in [----] when post-approval evidence revealed cancer links. Meridia cleared RCTs approved 1997withdrawn [----] after real-world signals showed elevated heart attacks/strokes. These arent outliers; theyre proof. Nothings perfect. Thats why we need real-world"
X Link 2026-02-01T17:59Z [----] followers, [----] engagements

"Youre right the ResQ201A phase [--] trial is actively recruiting and it randomizes post-ICI progressed advanced/metastatic NSCLC patients (ECOG 0-2) to: Experimental: N-803 + (PD-1) + docetaxel Control: docetaxel monotherapy Primary endpoint: OS. Docetaxel anchors both arms as the standard second-line backbone confirming chemos role for debulking and synergy post-ICI resistance. In PD-L1-low/negative NSCLC RWE/trials show chemo + PD-1 combos often outperform IO alone (higher ORR/PFS/OS). For terminal/advanced cancer patients (short horizons): RWE is key for accelerated approvals/expansions in"
X Link 2026-02-01T18:26Z [----] followers, [---] engagements

"Honestly speaking In my entire investing journey $IBRX is the first stock Ive ever genuinely hoped would dipso I could scoop up more shares on the cheap. Thats how rock-solid my confidence is in this companys long-term future. @Umbisam @alc2022"
X Link 2026-02-03T15:00Z [----] followers, [----] engagements

"@Humanspective We are going to need ANKTIVA $IBRX"
X Link 2026-02-04T04:18Z [----] followers, [----] engagements

"How much is a cancer cure #ANKTIVA $IBRX worths to you Were you aware that a cancer cure has existed for over a decade and just approved for lung cancer in Saudi Arabia. however that same drug is highly restricted in the United States Dr. Patrick Soon-Shiong went on air with Chris Cuomo and dropped a claim that shouldve https://t.co/mLdYPSREpe Were you aware that a cancer cure has existed for over a decade and just approved for lung cancer in Saudi Arabia. however that same drug is highly restricted in the United States Dr. Patrick Soon-Shiong went on air with Chris Cuomo and dropped a claim"
X Link 2026-02-04T04:27Z [----] followers, [----] engagements

"$IBRX is it time yet ANKTIVA is a national treasure @LoriMills4CA42 $IBRX OH HE WITH THE BIG HITTERS THIS IS GETTING GOOD https://t.co/AKZZmauEZy $IBRX OH HE WITH THE BIG HITTERS THIS IS GETTING GOOD https://t.co/AKZZmauEZy"
X Link 2026-02-04T09:52Z [----] followers, [----] engagements

"$IBRX Cup with handle https://t.co/PZWUBoHKbM Cup with handle https://t.co/PZWUBoHKbM"
X Link 2026-02-05T15:19Z [----] followers, [----] engagements

"$IBRX ANKTIVA: The pioneering and only FDA-authorized therapy specifically targeting lymphopenia reversal in cancer patientsnow demonstrating dramatic immune restoration (reversing severe lymphopenia with significant ALC increases) and extended survival across multiple solid tumor types including chemo-free combos in recurrent glioblastoma where median OS is not yet reached. The science is stacking uplymphopenia reversal isnt just a side benefit; its increasingly tied to better survival across tumor types. When the data continues to validate this the price of $IBRX will catch up big time."
X Link 2026-02-05T21:18Z [----] followers, [----] engagements

"$IBRX ANKTIVAs trillion-dollar potential ties directly into Dr. Patrick Soon-Shiongs bold vision: supercharging the immune systemspecifically by activating and proliferating natural killer (NK) cells T cells and memory T cellscould unlock massive $ value in longevity cancer treatment and beyond. #MAHA finally gets it https://twitter.com/i/web/status/2019527359242838078 https://twitter.com/i/web/status/2019527359242838078"
X Link 2026-02-05T21:43Z [----] followers, [----] engagements

"$IBRX demonstrated impressive relative strength during yesterdays broader market sell-off holding far better than many peers in biotech and beyond. This resilience highlights growing investor confidence in its explosive growth story (ANKTIVA ramp pipeline catalysts) while positioning it as a smart hedge against bearish macro pressuresmore buyers are likely stepping in on these dips. @DavidDin @Umbisam https://twitter.com/i/web/status/2019711556146118935 https://twitter.com/i/web/status/2019711556146118935"
X Link 2026-02-06T09:55Z [----] followers, [----] engagements

"$IBRX agree wholeheartedly $IBRX actually holding up pretty well while other popular names are getting hammered is a sign of whats to come in my opinion. Essentially we have just trapped more shorts over the last few weeks. And if we continue to hold this relative strength compared to the other popular $IBRX actually holding up pretty well while other popular names are getting hammered is a sign of whats to come in my opinion. Essentially we have just trapped more shorts over the last few weeks. And if we continue to hold this relative strength compared to the other popular"
X Link 2026-02-06T10:00Z [----] followers, [----] engagements

"$IBRX 🚀 ANKTIVA turns Saudi Arabia into CANCER MECCA #1 SFDA accelerated approvals Jan 26: WORLD-FIRST for metastatic NSCLC (w/ checkpoint inhibitors) + BCG-unresponsive bladder CIS ( papillary) 💥 Elite med tourists flock to Riyadhs King Faisal HospNK/T-cell revival reverses lymphopenia adds YEARS to life vs. FDAs Big Pharma stall 😂 Dr. Pat + His Excellency Bandar al-Knawys BioShield Summit: ALL tumors next While US patients are waiting. @DrMakaryFDA APPROVE LYMPOPENIA NOW Wealthy flock in stock MOONSHOTshorts lose #MAHA @DrPatrick @SenRonJohnson @bullishbruk I am from Saudi Arabia and Ive"
X Link 2026-02-06T15:46Z [----] followers, [----] engagements

"$IBRX My own 2cents ANKTIVA doesnt rely on political backingits a legitimate breakthrough for reversing lymphopenia (low NK/T-cell counts that cripple immunity in cancer patients). As a U.S. citizen I welcome any positive nods (including from leaders) but its value is universal: restoring immune competence benefits everyone everywhere. The real barrier is Big Pharma defending their turf but thats fading. With strong data mountingFDA Expanded Access for lymphopenia in solid tumors Saudi approvals for NSCLC and bladder cancer (world-firsts for subcutaneous IL-15 in some indications) ongoing"
X Link 2026-02-06T18:17Z [----] followers, [----] engagements

"When #LadyAnktiva speaks we listen $IBRX Unleash ANKTIVA NATIONWIDE for ALL cancer Patients. No More patient by patient approvals. Cancer Patients do not have time to wait. Every oncologist should be able to give Patients to option of choice #ANKTIVA @bullishbruk Unleash ANKTIVA NATIONWIDE for ALL cancer Patients. No More patient by patient approvals. Cancer Patients do not have time to wait. Every oncologist should be able to give Patients to option of choice #ANKTIVA @bullishbruk"
X Link 2026-02-06T21:53Z [----] followers, [----] engagements

"$IBRX led by Dr. Patrick Soon-Shiong pioneers Immunotherapy 2.0activating NK/T/memory cells to reverse lymphopenia defeat cancer/infections and advance longevity. Consequential and BigPharma in the making. ANKTIVA: Chemo-free durable responses. Early approvals: US/UK/EU & Saudi FDA NMIBC CIS papillary + SC metastatic NSCLC w/CPI (world-first beyond bladder). Momentum: [----] rev $113M (700% YoY growth); strong quarterly surge. Data: High 3-yr survival cystectomy avoidance long remissions. Pipeline: ResQ215B P2 launched: Chemo/lympho-free CAR-NK + ANKTIVA + ritux in indolent NHL (Waldenstrms)."
X Link 2026-02-07T22:29Z [----] followers, [----] engagements

"Spot on Mohammed. Meeting Dr. Soon-Shiong and seeing Saudis real commitment sealed itlong-term transformative bets like ANKTIVAs SFDA approvals. Hes a humble visionary focused on saving lives. $IBRX isnt just a stock; its the mission to protect our loved ones. I too have a conviction. Long-term. In this together. Thank you @DrPatrick I met Dr. Patrick Soon-Shiong (@DrPatrick) in Saudi Arabia and spoke with him personally. After the conference I invested heavily in $IBRX not as a trade but as conviction. My decision was driven by two core reasons: Saudi Arabias involvement because when Saudi I"
X Link 2026-02-07T23:07Z [----] followers, [----] engagements

"Immunity has been the core focus all along. We havent even scratched the surface of what ANKTIVA can truly achieve. I firmly believe it has the potential to become one of the blockbuster drugs of our generation. $IBRX @Umbisam $IBRX A quick google search will confirm my thoughts about the potential benefit of Anktiva in Alzheimers disease. There is an association between low ALC and Disease. When IBRX is cash positive maybe they would consider a trial. Expensive it will be. $IBRX A quick google search will confirm my thoughts about the potential benefit of Anktiva in Alzheimers disease. There"
X Link 2026-02-08T01:36Z [----] followers, [----] engagements

"Hands down @grok is one of the most intelligent of all. $IBRX @MartinezAyren @bigdickee Imagine the stock market is like a big playground where people buy and sell shares of companies like trading toys. $IBRX is a company that makes medicine. Normally trading happens during "playtime" (market hours). But after closing or before opening some big kids trade in a @MartinezAyren @bigdickee Imagine the stock market is like a big playground where people buy and sell shares of companies like trading toys. $IBRX is a company that makes medicine. Normally trading happens during "playtime" (market"
X Link 2026-02-08T02:45Z [----] followers, [----] engagements

"@StockChaser_ $IBRX At least look at it.potential is there for sure"
X Link 2026-02-08T19:50Z [----] followers, [---] engagements

"$IBRX ANKTIVA @DrPatrick hmmmm maybe there is a connection I am just asking for a friend 🚨 BREAKING South African AIDS Vaccine Begins Human Trials. https://t.co/zRqBvZ8Og3 🚨 BREAKING South African AIDS Vaccine Begins Human Trials. https://t.co/zRqBvZ8Og3"
X Link 2026-02-08T20:30Z [----] followers, [----] engagements

"Not so evil BigPharma in the making @PhoenxLights we appreciate it $IBRX @LoriMills4CA42 Immunitybio's HR recruiting video Amazing History and the end of cancer and infectious diseases is happening now Watch and share with all @DrPatrick @ImmunityBio https://t.co/K1qsOYnbdE Immunitybio's HR recruiting video Amazing History and the end of cancer and infectious diseases is happening now Watch and share with all @DrPatrick @ImmunityBio https://t.co/K1qsOYnbdE"
X Link 2026-02-09T13:59Z [----] followers, [----] engagements

"$IBRX Riyadh 2026: Igniting Immunotherapy [---] Anktiva + NK Cell Power for Breast Lung Prostate GBM & Beyond @DrMakaryFDA The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership in Saudi and setting the launch of Anktiva with NKcell therapy- immunotherapy [---] The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership"
X Link 2026-02-09T16:48Z [----] followers, [----] engagements

"$IBRX I agree wholeheartedly @DrPatrick $IBRX lets not lose sight that the leader of this project has the tenacity of a Michael Jordan the brains of a Jonas Salk and the salesmanship of a Steve Jobs. Bet on the man $IBRX lets not lose sight that the leader of this project has the tenacity of a Michael Jordan the brains of a Jonas Salk and the salesmanship of a Steve Jobs. Bet on the man"
X Link 2026-02-10T02:57Z [----] followers, [----] engagements

"$IBRX you think so How about heading to all time high $46 @Umbisam @alc2022 $IBRX may be headed back to recent highs. https://t.co/caDij17N8H $IBRX may be headed back to recent highs. https://t.co/caDij17N8H"
X Link 2026-02-10T02:59Z [----] followers, [----] engagements

"$IBRX crew has anyone else noticed Every time @adamfeuerstein drops his latest hit piece on IBRX the stock pumps like clockwork. Coincidence Nah. The mans basically our secret bullish catalyst at this point. Keep the shade coming Adam youre doing the Lords work (for the longs). @Umbisam @alc2022 @Alhmd120690 https://twitter.com/i/web/status/2021219542148497667 https://twitter.com/i/web/status/2021219542148497667"
X Link 2026-02-10T13:47Z [----] followers, [----] engagements

"$IBRX do you believe RFK and @DrMakaryFDA are trying to sanitize the FDA IMO: The FDA isnt a health agency and never has beenits a captured corrupt institution run by Big Pharma loyalists. After the scamdemic disaster zero real prosecutions of the worst offenders proves the rot goes all the way to the top. The agency has zero remaining credibility; an FDA stamp now means suspicion not safety for millions. Until the most blatant criminals are publicly prosecuted and removed trust cannot return. The worst long-term positions must be gutted and replaced with truly independent unowned people."
X Link 2026-02-10T14:09Z [----] followers, [----] engagements

"Hell yeah @Alhmd120690 prophecy or conviction Either way youre the man $IBRX to $15+ by Feb end Ballsy call. Games in Riyadh not Wall Street: SFDA approvals for ANKTIVA in all cancer types coming regional office plans MENA momentum. Wall Streets catching up slow but Saudi ties = big unlock. Some remember others regret. Reposted saved riding. Print that $15+. 🚀 #Anktiva #SaudiHealthcare My call: $IBRX above $15 before the end of February. This is a conviction not noise. If it doesnt happen Ill run a cash giveaway by draw for followers then Ill close this account. Remember this clearly: The"
X Link 2026-02-10T22:40Z [----] followers, [----] engagements

"@SaiseiInvesting @ParhamLevi1 @YahooFinance Kkkk RS on $7 stock never heard of it. Usually RS is for stock below $1 to gain Nasdaq listing requirement"
X Link 2026-02-11T23:04Z [----] followers, [--] engagements

"$IBRX welcome to the real problem. At least this feels like a relief it wasnt only happening to us. Prasad overruled FDA staff to reject Modernas flu vaccine application https://t.co/YR7hS86BHc via @lizzylaw Prasad overruled FDA staff to reject Modernas flu vaccine application https://t.co/YR7hS86BHc via @lizzylaw"
X Link 2026-02-12T17:15Z [----] followers, [----] engagements

"@alc2022 So much respect for ALC"
X Link 2026-02-12T17:35Z [----] followers, [---] engagements

"$IBRX @VPrasadMDMPH @DrMakaryFDA Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): Its fully approved in the US for one rare form of bladder cancer but not for the common form most patients have. So even though the same drug is already FDA-approved and https://t.co/jb46zpPbPL Dr. Patrick Soon-Shiong just exposed a maddening FDA reality on his own approved cancer drug (Anktiva): Its fully approved in the US for one rare form of bladder cancer but not for the common form most patients have. So even though the same drug is already"
X Link 2026-02-12T17:39Z [----] followers, [----] engagements

"@pdsandiego @JBluePolaski_ @adamfeuerstein @DrPatrick Like I have stated every time Adam starts bashing $IBRX the stock goes up Go figure"
X Link 2026-02-12T20:42Z [----] followers, [---] engagements

"@alc2022 In due time $DUOL $1T $HIMS $1T $IBRX $1T"
X Link 2026-02-12T21:36Z [----] followers, [---] engagements

"@IdenixH Have you checked the recent NCCN updates Might have ANKTIVA as Prefered which insurance usually cover"
X Link 2026-02-13T16:27Z [----] followers, [--] engagements

"$IBRX DD Strong conviction + patience = potential life-changing moment. My price target: $65 DYOR. Not financial advice. $IBRX Weak hands are getting flushed out. I made that mistake with my [-----] options on $ASTS. Looking back I got scared out of most of my position around $5. I sold my last [----] shares at $111.00 I will not do this with$IBRX. A short squeeze is coming. $IBRX Weak hands are getting flushed out. I made that mistake with my [-----] options on $ASTS. Looking back I got scared out of most of my position around $5. I sold my last [----] shares at $111.00 I will not do this with$IBRX."
X Link 2026-02-13T16:31Z [----] followers, [----] engagements

"Friends please join me asking this question. Dear Mr. Feuerstein why the intense focus With thousands of biotech CEOs posting daily it seems youre glued to your screen specifically awaiting Dr. Soon-Shiongs updates. It raises the question: is this a personal obsession or have you been unofficially tasked by @DrMakaryFDA to monitor and counter every breakthrough he shares Your immediate reactions suggest a level of coordination that goes far beyond standard journalism. Asking for a friend. @DrPatrick $IBRX @adamfeuerstein This is not a Saudi-USA Biotech Alliance its a Saudi @DrPatrick $IBRX"
X Link 2026-02-15T19:25Z [----] followers, [----] engagements

"So far so good BIOTECH I am in $CADL $IBRX $IOVA and $SLS.for now out on $ATOS and $CAPR"
X Link 2026-01-20T22:17Z [----] followers, [----] engagements

"$IBRX shorts trapped in hell: 135M shares short (40%+of float) Borrow pool Ghost town only 100k850k shares left vanishing quick. CTB 8.59% and climbing bleeding shorts daily just to hold. Days to cover: [--] one spark and theyre forced to chase for a week+. Gamma ramp primed: heavy calls loading $7.50$10 strikes dealer hedging = auto-buy pressure. ANKTIVA momentum + institutions stacking + retail recalling shares = borrow spigot shutting off. Exit Zero. Plan Panic. Outcome Shorts get absolutely demolished. Hold the line smash $7.50$8 on volume cascade to $15$25+. Still short $IBRX Times up."
X Link 2026-02-10T23:03Z [----] followers, [----] engagements

"$IBRX shorts got PLAYED. They piled in heavy on insider FDA dirtbetting on papillary rejection/delays thinking ANKTIVA was dead in the water. Then Dr. Pat drops the HAMMER: Saudi FDA slams accelerated approvals for ANKTIVA in BLADDER AND NSCLC first worldwide subQ IL-15 wins revenue exploding to 700% YoY Saudi rollout + partnerships fueling cash without waiting on FDA resub. Now: 135M+ SS borrow ZERO CTB 8-9% Trapped hemorrhaging and covering means MOONSHOT FDA curveball NahSaudi curveball nuked their thesis. One more catalyst (resub data ASCO buzz earnings beat) and this EXPLODES FOMO"
X Link 2026-02-12T13:17Z [----] followers, [----] engagements

"$IBRX Everyone acts like shorts are invincible phantoms lurking in the shadows. Reality check: tons of fund managers are sniffing out weakness right now ready to pile in squeeze the bears dry and walk away with billions. I am in How about you DYOR ANKTIVA @Alhmd120690 @Umbisam https://twitter.com/i/web/status/2021945387406229964 https://twitter.com/i/web/status/2021945387406229964"
X Link 2026-02-12T13:52Z [----] followers, [----] engagements

"$DUOL Just added a few more I think this might be the bottom or close to it. This year my best friends are shorts They gave me $2.23 $IBRX and $112 $DUOL @alc2022 New $DUOL VP of AI. Ex Google Director of Engineering Workspace AI. https://t.co/EBErvt2M5h New $DUOL VP of AI. Ex Google Director of Engineering Workspace AI. https://t.co/EBErvt2M5h"
X Link 2026-02-13T20:05Z [----] followers, [----] engagements

"$IBRX stop loss raid Shorts last Hail Mary Remember not to long a go this was trading $1.95. Do your DD buy/sell and hold Life changing opportunities doesnt come easy @Umbisam @alc2022"
X Link 2026-02-13T20:14Z [----] followers, [----] engagements

"Dear Senator Moody I urge you to call on the FDAs and demand an explanation to the glaring double standard in oncology approvals. In June [----] the FDA granted Mercks Keytruda a broad tissue-agnostic approval for MSI-high tumors by pooling data from five single-arm trials. Some tumor types had only N=1 or N=2 patients different doses were used and the entire approval rested on this combined dataset (see @DrPatrick ). Merck received accelerated approval on the weakest possible evidence. Yet innovative biotechs such as ImmunityBio developing next-generation immunotherapies including IL-15"
X Link 2026-02-14T15:57Z [----] followers, [----] engagements

"Dear Dr. Pat I am a stock holder and do want a return on my investment however I have a far more important reason for championing ANKTIVA: it is a genuine breakthrough that can spare patients from life-altering bladder removal give hope to those with advanced lung cancer and now reach people across the Middle East thanks to you and the Kingdoms visionary regulatory leadership. https://twitter.com/i/web/status/2022751010381312205 https://twitter.com/i/web/status/2022751010381312205"
X Link 2026-02-14T19:13Z [----] followers, [---] engagements

"$IBRX The historic collaboration between Dr. Patrick Soon-Shiong and the Saudi Food and Drug Authority (SFDA) has ignited a global paradigm shift in oncology. By granting the worlds first regulatory approval for the IL-15 superagonist ANKTIVA in combination with checkpoint inhibitors for lung cancer the SFDA has established itself as a premier global pioneer in biotech regulation. This bold move transcends traditional healthcare boundaries officially launching the era of Immunotherapy [---]. Through Dr. Pats visionary science and the SFDAs agile leadership they are not just treating diseasethey"
X Link 2026-02-15T16:29Z [----] followers, [----] engagements

"Sir this is remarkable a truly historic alignment It is inspiring to witness @DrPatrick and @NGHAnews His Excellency Bandar Alknawy coming together during such a spiritually and symbolically significant time. The Saudi Food and Drug Authority (SFDA) has shown world-class leadership by moving beyond the status quo to embrace Immunotherapy [---]. This isn't just a clinical breakthrough; it is a paradigm shift for humanity. By prioritizing the 'good of humanity' over bureaucratic gatekeeping the SFDA and the Saudi-USA Biotech Alliance are proving that the Kingdom is now the global frontier for the"
X Link 2026-02-15T19:10Z [----] followers, [----] engagements

"@RogerJStoneJr @DrPatrick @ImmunityBio Roger thank you for exposing the availability of the cure and the @US_FDAs obstruction. We truly appreciate it"
X Link 2026-02-15T22:19Z [----] followers, [---] engagements

"@DrPatrick Sir Happy Sunday From NCIs #1 Choice to the World Bank of NK Cells Cancer Doesnt Stand a Chance God of NK cell Thank you"
X Link 2026-02-01T16:22Z [----] followers, [---] engagements

"I believe Elon Musk with his groundbreaking advancements in technology and Dr. Patrick Soon-Shiong through his pioneering work in biology immunotherapy and cancer treatments like ANKTIVA and next-generation immune activation therapies will stand as two of the most consequential figures of our time. $IBRX https://twitter.com/i/web/status/2019397046814257177 https://twitter.com/i/web/status/2019397046814257177"
X Link 2026-02-05T13:05Z [----] followers, [----] engagements

"What truly sets Dr. Patrick Soon-Shiong and Elon Musk apart is their shared unwavering focus on advancing humanity whether through revolutionary immunotherapy and cancer breakthroughs like ANKTIVA or through transformative technologies in space AI neural interfaces and sustainable energy rather than being primarily driven by profit. That rare priority on genuine progress over pure financial gain is what makes both of them so remarkable and inspiring. https://twitter.com/i/web/status/2019412114402628078 https://twitter.com/i/web/status/2019412114402628078"
X Link 2026-02-05T14:05Z [----] followers, [---] engagements

"Well respectfully I disagree. Elons drive might look self-focused but its about scaling solutions for humanity much like Dr. Soon-Shiongs. Theyve got mutual respect public props and joint forums. Give it time; collaborations between titans like them could still happen especially with aligned goals in AI-biotech crossovers or global health. $IBRX https://twitter.com/i/web/status/2019418938111635602 https://twitter.com/i/web/status/2019418938111635602"
X Link 2026-02-05T14:32Z [----] followers, [--] engagements

"$IBRX Harvard Scientist and Ex-UCLA Surgeon Unite in Riyadh to Tackle Humanitys Greatest Health Challenges What a beautiful moment caught on camera in Riyadh. A brilliant scientist from Harvard meeting for the first time with an Ex UCLA surgeon discussing how we together solve humanitys biggest health challenges brought together by His Excellency Bandar working together not as https://t.co/3UJGKl1VOs What a beautiful moment caught on camera in Riyadh. A brilliant scientist from Harvard meeting for the first time with an Ex UCLA surgeon discussing how we together solve humanitys biggest health"
X Link 2026-02-05T15:26Z [----] followers, [---] engagements

"$IBRX #Bioshield #Anktiva has been approved in UK. Great news for United Kingdom MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer The Medicines and Healthcare products Regulatory Agency (MHRA) has today [--] July [----] approved nogapendekin alfa inbakicept (Anktiva) for adu https://t.co/YqVc33qMj6 MHRA approves nogapendekin alfa inbakicept to treat adult patients with non-muscle invasive bladder cancer The Medicines and Healthcare products Regulatory Agency (MHRA) has today [--] July [----] approved nogapendekin alfa inbakicept (Anktiva) for"
X Link 2025-07-04T15:21Z [----] followers, 136K engagements

"$IBRX "BioShield" (ANKTIVA) @drpatrick The BioShield is not a vaccine in the traditional sense but rather an immunotherapy designed to restore and activate the patient's own immune system to fight cancer and potentially other infections like Long COVID. It works by stimulating Natural Killer (NK) and T cells which are critical for a patient's immune response. IT CLEARS LongCovid @SecKennedy @peterthiel @NIHDirector_Jay @DrMakaryFDA"
X Link 2025-08-30T13:50Z [----] followers, [----] engagements

"$IBRX it is time for @drpatrick to come out and publicly expose Francis Collins (then NIH director) and Tony Fauci what both did to exclude the only therapy that cleared COVID virus form our body #Bioshield ANKTIVA by @ImmunityBio from warp speed in [----]. @RealAlexJones @newstart_2024 @realDonaldTrump @RWMaloneMD"
X Link 2025-09-01T18:35Z [----] followers, [----] engagements

"$IBRX $IBRX is the company that could save the world 🧵 https://t.co/uvWSujlLOM $IBRX is the company that could save the world 🧵 https://t.co/uvWSujlLOM"
X Link 2025-10-24T18:17Z [----] followers, 30.2K engagements

"Massive undeniable catalyst in biotechnology: a true cancer cure that skips chemo entirely IMO $IBRX is about to pull the exact same move as $QMMM did from $2.08 $303. The question isnt if its when. Patience pays 🚀💉"
X Link 2025-11-08T14:48Z [----] followers, [----] engagements

"🚨 BREAKING THE CANCER MATRIX 🚨 Yo @elonmusk @JoeRogan bring @drpatrick on the pod RIGHT NOW Were DONE with chemo & radiation that fail 90%+ of patients and destroy lives. BioShield is the paradigm-shifting nuclear option weve all been waiting for an actual immune BIOSHIELD thats saving people BIG TIME. Whos ready to end cancer in our lifetime 🔥🔥🔥 Tag everyone. Retweet if you want this convo to go VIRAL. $IBRX #ANKTIVARevolution #BioShieldRevolution #CancerKiller #EndChemoEra"
X Link 2025-11-11T00:42Z [----] followers, [----] engagements

"$IBRX @drpatrick @US_FDA are you listening Here is a proud American mother plea to the FDA: FDA: IM BEGGING AS A MOTHER. My sonStage [--] colon cancer. Standard of care Exhausted. Hes perfect for the Anktiva lymphopenia trialexcept ONE count [--] points too high Hes a fit devoted young dadtucking in his babies dreaming of their graduations. Cancers trying to steal him. Compassionate use. PLEASE Anktivas saving lives across cancersdont let a number orphan my grandchildren. He deserves to fight. To live. To hold them. FDASAVE MY BOY #RightToTry @FDA 😭🙏 @DrMakaryFDA @VPrasadMDMPH @SecKennedy"
X Link 2025-11-16T03:59Z [----] followers, 13.5K engagements

"Here are my top SC biotech stocks $CADL $IBRX $IOVA these three among others may be a life changing opportunity $CAPR that was huge bank Not a financial advice please do your own DD"
X Link 2025-12-08T14:24Z [----] followers, [----] engagements

"$BRX ANKTIVA ANKTIVA Safety (FDA 2024): Favorable profile; similar to BCG alone. Mostly mild local effects. Common: dysuria hematuria urgency/frequency UTI chills fever. Severe: rare (03%). No trial deaths. CHIMO/RADIATION/KEYTRUDA IS A $200B BUSINESS AND NOT SURE IF ANY OF THESE DONATION (BRIBES) AMOUNTS ARE ACCURATE BUT Now you know why the FDA is not able to approve ANKTIVA safest than any of the poison they approved including the one just approve J&Js INLEXZO and while you and your loved ones are dying. @DrMakaryFDA @SecKennedy @SenRonJohnson @POTUS @VPrasadMDMPH @LoriMills4CA42 Check out"
X Link 2025-12-25T15:51Z [----] followers, [----] engagements

"$CADL $IBRX $IOVA Analysts thought $PLTR was a consulting company in [----]. They were wrong and now we are up 27X. $HIMS today is the same. Analysts thought $PLTR was a consulting company in [----]. They were wrong and now we are up 27X. $HIMS today is the same"
X Link 2025-12-23T18:34Z [----] followers, [----] engagements

"@OccupyDemocrats Well I dont know if he owns the said equities but if he does this just proves that he is a smart businessman and definitely he doesnt mix business with politics"
X Link 2023-04-27T01:19Z [----] followers, 60.2K engagements

"@OccupyDemocrats Where is the leaked tape"
X Link 2023-05-02T02:13Z [----] followers, 48.6K engagements

"@OccupyDemocrats Thank you for the predictions and confirmation of Trumps [----] victory"
X Link 2023-05-05T01:22Z [----] followers, 30.9K engagements

"@OccupyDemocrats At the end of the day it is all about the money. reputation my foot"
X Link 2023-05-05T17:23Z [----] followers, 43K engagements

"@Spriter99880 I have been saying war is not a comedy show and it is not a joke but Zelenskyy thought otherwise"
X Link 2023-05-07T16:30Z [----] followers, 16.1K engagements

"@Spriter99880 Translation: please dont quit on us and give us more money.how about one for the road"
X Link 2023-05-08T03:05Z [----] followers, 18.8K engagements

"@Spriter99880 If Kissinger knows about anything it is about China"
X Link 2023-05-08T22:42Z [----] followers, 17.1K engagements

"@Travis_in_Flint To me the audience look like middle America and the majority liked what Trump has to say"
X Link 2023-05-12T01:54Z [----] followers, [----] engagements

"@CalltoActivism Never liked Giuliani he gives me the creeps"
X Link 2023-05-16T13:03Z [----] followers, 119.9K engagements

"@CalltoActivism Congress should have a term limit specifically for those to old or to sick to serve"
X Link 2023-05-18T15:39Z [----] followers, 12.5K engagements

"@Spriter99880 I can hear it now African leaders are laughing Kkkkkkk"
X Link 2023-05-25T00:34Z [----] followers, [----] engagements

"@SuleimanAbdell7 Fano forever "
X Link 2023-08-20T20:06Z [----] followers, [----] engagements

". [--] [--] [--] [--] [--] "
X Link 2023-08-20T21:35Z [----] followers, [----] engagements

"@SuleimanAbdell7"
X Link 2023-08-29T22:02Z [----] followers, 12K engagements

"@NatnaelMekonne7"
X Link 2023-08-30T19:13Z [----] followers, 16.3K engagements

"@SuleimanAbdell7 /"
X Link 2023-09-08T22:58Z [----] followers, [----] engagements

"@SuleimanAbdell7 "
X Link 2023-09-09T22:33Z [----] followers, [----] engagements

"@nexta_tv @sharkbiotech If this continues I might volunteer to go and fight side by side with IDF I am not even a Jew"
X Link 2023-10-29T18:58Z [----] followers, [----] engagements

"#bioshield # ANKTIVA of @ImmunityBio $IBRX @drpatrick the great scientist go where no scientist has gone ever before The beginning of the end of Evil BigPharma. Dr. Pat THANK YOU I wil draft an X article today to discuss this finding that every [--] percent drop in NK and T cells results in [--] percent increased risk of death in lung cancer Preventable today with Bioshield since we activate NK cells with a subcutaneous jab. Your body is the factory. https://t.co/HLiCrXKkAc I wil draft an X article today to discuss this finding that every [--] percent drop in NK and T cells results in [--] percent"
X Link 2025-06-07T18:01Z [----] followers, [----] engagements

"And guess what multiplies these Killer cells A drug just got approved last year called #ANKTIVA #Bioshield Lymphocytes- stimulator by @ImmunityBio @drpatrick spent the last [--] years of his life and $3B of his hard earned money invented it. Instead of only for bladder cancer Hope @fda approve it for all cancer indications soon. Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. 🔬 Alex Ritter / RitterLab https://t.co/sQZ7Som3V9 Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. 🔬 Alex Ritter / RitterLab"
X Link 2025-07-09T01:45Z [----] followers, 85.3K engagements

"We now know mRNA vaccine is not 100% effective against COVID may even be harmful to some but according to @drpatrick (world renowned scientist surgeon) #bioshield #ANKTIVA by @ImmunityBio $IBRX is effective clearing out the spike protein (Covid/vaccine) from our body and has the ability to stimulate and strength our own God given immunity against other illness including cancer with more than [--] years safety data available. Isnt it time to authorize and clear #LongCovid @SecKennedy @DrMakaryFDA @NIHDirector_Jay @megynkelly @TuckerCarlson Dr. Patrick Soon-Shiong a pioneering surgeon and"
X Link 2025-08-09T15:09Z [----] followers, [----] engagements

"$IBRX with more good news BigPharma is doubling down and shorting IBRX to death. now 85% 80M+ shorted shares. Sooner or later they have to cover and meantime we are accumulating. The time is on our side. Patience PT $65"
X Link 2025-08-13T13:33Z [----] followers, [----] engagements

"$IBRX #Bioshield couldnt repost it enough The message needs to be out repeatedly so everyone can experience a paradigm shift. We need it Huge Thanks to @newstart_2024 he is doing his part. Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's a devastating paradox at the heart of modern cancer care. As articulated by Dr. Patrick Soon-Shiong we are systematically poisoning the body's single most powerful https://t.co/DzjEcfAZGF Chemotherapy's Fatal Flaw: We're Destroying the Very System That Can Save Us. This isn't just an opinion. It's"
X Link 2025-08-24T17:04Z [----] followers, [----] engagements

"$IBRX a prophecy #ANKTIVA is going to be huge. you know when you are in the know thanks ANKTIVA. Remember that word/therapy. ANKTIVA. Remember that word/therapy"
X Link 2025-08-28T17:26Z [----] followers, [----] engagements

"$IBRX if you are a cancer patient or suffering from LongCovid you should read this and ask questions. It is your life or death @US_FDA @DrMakaryFDA Dr. P.S.S: Next week we will share our data in [--] patients with lung cancer who failed chemo and some who failed both chemo and radiation.But why are we waiting to catch patients once they already in a deep hole Why not protect their cells from the outset @VPrasadMDMPH @POTUS @SecKennedy @NIHDirector_Jay Next week we will share our data in [--] patients with lung cancer who failed chemo and some who failed both chemo and radiation and all [--] who"
X Link 2025-08-31T03:40Z [----] followers, [----] engagements

"$IBRX #Bioshield This great news is a Labor Day gift not only for Lung-cancer patients but a hope for all type of cancer patients including people suffering from LongCovid. Long live Dr. PSS. Thank you @adamfeuerstein @drkashsarabi @DrMakaryFDA @RWMaloneMD NCI supported PRAGMATICA lung trial failed but established real world survival after chemo of [--] mo. Our Bioshield trial in lung patients who progressed show when NK & T cells are activated survival is doubled & some patients live 4+ yrs in late stage of cancer Coming this week https://t.co/O1ysbaJyV5 NCI supported PRAGMATICA lung trial"
X Link 2025-09-01T20:08Z [----] followers, [----] engagements

"$IBRX #Bioshield #Anktiva by @ImmunityBio getting rid of Cancer Tumors and LongCovid. @DrMakaryFDA Another inspiring story on the power of ANKTIVA Bioshield in driving NK cells even across the blood brain barrier to the brain tumor. Recurrent glioblastoma trial now open https://t.co/IA7l3lUvGi https://t.co/TrrmgEVcFO Another inspiring story on the power of ANKTIVA Bioshield in driving NK cells even across the blood brain barrier to the brain tumor. Recurrent glioblastoma trial now open https://t.co/IA7l3lUvGi https://t.co/TrrmgEVcFO"
X Link 2025-09-04T15:11Z [----] followers, [----] engagements

"$IBRX Lung Cancer patients survival tripled (7months vs 21Months) with #Bioshield #Anktiva a $50B+ company in the making Weve announced new paradigm-changing findings from the Phase [--] QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural killer and T cells) in patients with checkpoint inhibitor-resistant advanced non-small cell lung cancer https://t.co/aTxCJgqQnZ Weve announced new paradigm-changing findings from the Phase [--] QUILT-3.055 study demonstrating ANKTIVA (nogapendekin alfa inbakicept-pmln) reverses lymphopenia (low natural"
X Link 2025-09-08T13:31Z [----] followers, [----] engagements

"$IBRX #bioshield #Anktiva paradigm shifts slowly but surely Oncologists from Ohio State at WCLC25 demonstrate that absolute lymphocyte count (ALC) matters. When lymphocytes are recovered the survival rate is doubled to [-----] months The cancer world is waking up to the concept of ALC and how chemo-radiation destroys our NK and T cells. https://t.co/g6FJTvwLpI Oncologists from Ohio State at WCLC25 demonstrate that absolute lymphocyte count (ALC) matters. When lymphocytes are recovered the survival rate is doubled to [-----] months The cancer world is waking up to the concept of ALC and how"
X Link 2025-09-08T21:26Z [----] followers, [----] engagements

"$IBRX so happy to hear so far @GretchMick is cancer free #bioshield #anktiva @DrMakaryFDA @POTUS @SecKennedy @NIHDirector_Jay @drpatrick CT Scan Results #coloncancer #cancer @ImmunityBio #bioshield https://t.co/daqrsIAyVH CT Scan Results #coloncancer #cancer @ImmunityBio #bioshield https://t.co/daqrsIAyVH"
X Link 2025-09-08T23:16Z [----] followers, [----] engagements

"Well how about approving Bioshield (ANKTIVA) for Lymphopenia I am sure you know @drpatrick talk to him Harnessing AI to make America healthy again By Marty Makary Jim O'Neill Imagine what would happen if the government put Boeing in charge of airline safety or if fast-food chains set national nutrition standards. Such an irony took place when then-President Joe Biden allowed Harnessing AI to make America healthy again By Marty Makary Jim O'Neill Imagine what would happen if the government put Boeing in charge of airline safety or if fast-food chains set national nutrition standards. Such an"
X Link 2025-10-09T17:09Z [----] followers, [----] engagements

"It amazes me that here we have #bioshield ANKTIVA already available doing almost the same thing but people ignoring it and looking the other way if #bioshield was presented by BigPharma instead of @drpatrick everyone including @ScottAdamsSays would have called it a breakthrough and a miracle of the century. @newstart_2024 @megynkelly @TuckerCarlson @Rainmaker1973 @seanspicer Next-gen vaccine prevents up to 88% of multiple aggressive cancers Paul McClure New Atlas A next-generation cancer vaccine has shown stunning results in mice preventing up to 88% of aggressive and difficult-to-treat"
X Link 2025-10-11T16:40Z [----] followers, [----] engagements

"Let that sink in It's wild: A patient will bravely endure chemo's harsh effects but the suggestion to cut sugar eat clean and detox is treated as radical unscientific nonsense. The conditioning is real. It's wild: A patient will bravely endure chemo's harsh effects but the suggestion to cut sugar eat clean and detox is treated as radical unscientific nonsense. The conditioning is real"
X Link 2025-10-15T11:24Z [----] followers, [----] engagements

"I have a feeling #bioshield ANKTIVA for LongCovid or Lymphopenia is going to be on the next list FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability domestic production or meeting an unmet public health need. https://t.co/oUuEsAnBQ2 FDA will be proactive in advancing decisions on medicines serving a key national priority: affordability domestic production or meeting an unmet public health need. https://t.co/oUuEsAnBQ2"
X Link 2025-10-16T22:46Z [----] followers, [----] engagements

"Urgent Call to Action: Free #Bioshield #ANKTIVA from FDA Delays and Save Cancer Patients Lives. Dear @CalleyPoche and @DrMakaryFDA @US_FDA Leadership Every day that #ANKTIVA remains trapped in regulatory limbo is another day cancer patients are denied a proven life-extending therapy. #Bioshield the innovative immunotherapy behind ANKTIVA has already demonstrated remarkable efficacy in clinical trialsdelivering complete remissions in high-risk BCG-unresponsive bladder cancer patients where no other options exist. This isnt experimental hope; its validated science backed by peer-reviewed data"
X Link 2025-11-01T16:20Z [----] followers, [----] engagements

"Sir these 10000+ pages arent just paper theyre parents praying for one more birthday children begging for their moms laugh spouses clinging to empty beds at night. Every sheet is a soul screaming for hope. Your clinic answering each one Thats humanity at its rawest most beautiful. A Cancer Hotline + podcast YES. A thousand times YES. Let survivors voices crack through the airwaveslet ANKTIVAs 10-year miracles shatter the silence. Give families something to hold onto when scans steal their breath. Im crying and voting YES. Who else feels this in their bones 🙏💔 #ANKTIVA #CancerHotline"
X Link 2025-11-17T02:05Z [----] followers, [----] engagements

"$BRX ANKTIVA This account is fake. the claim based on Arizona is obviously incorrect . @Dr_Arana_Yi"
X Link 2025-12-26T16:50Z [----] followers, [---] engagements

"#Bioshield #Anktiva a #cancercure that @US_FDA holding hostage @RealAlexJones @newstart_2024 @Rainmaker1973 @VigilantFox @megynkelly @seanspicer @TuckerCarlson Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating the NK cells and T cells we can convert cancer into a chronic disease with long-term survival regardless of tumor types. Current https://t.co/Lczvpeqc6z Since [----] we proposed to the FDA and completed trials across multiple tumor types @ImmunityBio to address the hypothesis that by stimulating"
X Link 2025-10-13T19:32Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing